Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.52, p.119-125, 2005 |
||
Title: Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis | ||
Author: J. MORAVCOVA, J. REGNER, D. MOUCKOVA, K. FISER, V. ZMEKOVA, R. MALACOVA, K. MICHALOVÁ, H. KLAMOVA | ||
Abstract: Monitoring of BCR-ABL transcript level is widely used in chronic myeloid leukemia (CML) to follow up response to
therapy. In this study we compare abilities of two quantitative RT-PCR assays to characterize the disease status in CML patients: RT-PCR quantifying the BCR-ABL transcript concentration and RT-PCR determining the BCR-ABL/BCR transcript ratio (R). We demonstrate that in non-responders only R, but not BCR-ABL, unambiguously characterizes the state of disease. Moreover, R values >1 found in all poor responders indicate lower BCR expression compared to BCR-ABL in these
patients. Our results demonstrate the importance of BCR-ABL/BCR transcript ratio for the disease status and the disease prognosis characterization and suggest a possible role of the normal BCR gene expression in CML pathogenesis. |
||
Keywords: CML, BCR-ABL, BCR-ABL/BCR, quantitative RT-PCR, disease status, disease prognosis | ||
Year: 2005, Volume: 52, Issue: | Page From: 119, Page To: 125 | |
|
download file |
|